2026年6月最新影响因子数据已更新,欢迎查询使用。如果您对期刊系统有任何需求或者问题,欢迎反馈给我们。
| 热门AI工具: |
论文引言生成
New
AI 写作痕迹检测
Hot
学术改写降重
论文摘要生成
参考文献挖掘工具
审稿意见辅助撰写
|
查看更多AI工具 >> |
| 近期推荐: | 热 全流程投稿协助套餐服务 | 热 SCI论文AI润色+人工QC服务 | 热 Springer Nature特刊征稿 |
| |
| 基本信息 | 登录收藏 | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名字![]() | MOLECULAR CANCER THERAPEUTICS MOL CANCER THER (此期刊被最新的JCR期刊SCIE收录) LetPub评分 7.7
54人评分
我要评分
声誉 8.6 影响力 6.6 速度 9.3 | |||||||||||||||||||||
| 期刊ISSN | 1535-7163 | 安装APP,查看期刊最新消息
| ||||||||||||||||||||
| E-ISSN | 1538-8514 | |||||||||||||||||||||
| 2025-2026最新IF (数据来源于网友提供) | 注册或登录后,查看IF | |||||||||||||||||||||
| 实时影响因子 | 截止2026年9月20日:4.493 | |||||||||||||||||||||
| 2025-2026自引率 | 1.4%点击查看自引率趋势图 | |||||||||||||||||||||
| 五年IF (数据来源于网友提供) | 6.395数据由网友[泽雪澜]收集提供 | |||||||||||||||||||||
| h-index | 157 | |||||||||||||||||||||
| CiteScore ( 2026年6月最新版) |
| |||||||||||||||||||||
| 期刊简介 |
| |||||||||||||||||||||
| 期刊官方网站 | http://mct.aacrjournals.org/ | |||||||||||||||||||||
期刊投稿格式模板 VIP专享 |
| |||||||||||||||||||||
| 期刊投稿网址 | http://mct.msubmit.net/cgi-bin/main.plex | |||||||||||||||||||||
| 该期刊中国学者近期发文 - New | MCT1 Inhibition Remodels the Tumor Immune Microenvironment for Enhanced Cancer Immunotherapy Author: Zhang, Yipeng; Liu, Chun; Han, Fuxin; Tong, Chuan; Guo, Yelei; Lu, Yuting; Han, Weidong; Wang, Yao Journal: MOLECULAR CANCER THERAPEUTICS. 2026; Vol. 25, Issue 8, pp. 1330-1341. DOI: 10.1158/1535-7163.MCT-25-1026 TAK-901 Targeted Inhibition of EGFR Activates Transcription Factor FOXO, Causing Cell-cycle Arrest and Apoptosis in Bladder Cancer Author: Lu, Lanpeng; Cheng, Hui; Liu, Shanhui; Tao, Yan; Fu, Shengjun; Lu, Jianzhong; Gong, Yuwen; Ding, Hui; Tian, Junqiang; Li, Lanlan; Wang, Zhiping Journal: MOLECULAR CANCER THERAPEUTICS. 2026; Vol. 25, Issue 8, pp. 1317-1329. DOI: 10.1158/1535-7163.MCT-25-0507 VHH-Based CAR-T Cells Targeting DLL3 Show High Efficacy in Small Cell Lung Cancer Models Author: Guo, Han; Yue, Chunjiang; Ma, Di; Zhou, Jingyi; Tang, Min; Sun, Rongze; Tian, Binle; Wang, Zhaoying; Xing, Yishu; Lv, Chenjun; Liu, Chuan; Yuan, Lin; Zhu, Xuekai; Feng, Yunfeng; Li, Qi Journal: MOLECULAR CANCER THERAPEUTICS. 2026; Vol. 25, Issue 8, pp. 1305-1316. DOI: 10.1158/1535-7163.MCT-25-0965 A Novel Attenuated CD122-Biased IL15 Mutein Promotes Strong NK and T Cell-Dependent Antitumor Immunity Author: Sun, Mengmeng; Wang, Shuang; Wu, Yue; Xin, Ruipu; Zhang, Shangting; Huang, Bo; Chen, Yan; Liang, Yu; Yu, Tengfei; Xu, Jianqing; Gu, Jijie; Wu, Lei Journal: MOLECULAR CANCER THERAPEUTICS. 2026; Vol. 25, Issue 7, pp. 1049-1063. DOI: 10.1158/1535-7163.MCT-25-0625 | |||||||||||||||||||||
| 期刊语言要求 | 经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件,不仅能满足MOLECULAR CANCER THERAPEUTICS的语言要求,还能让MOLECULAR CANCER THERAPEUTICS编辑和审稿人得到更好的审稿体验,让稿件最大限度地被MOLECULAR CANCER THERAPEUTICS编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务(包括SCI论文英语润色,同行资深专家修改润色,SCI论文专业翻译,SCI论文格式排版,专业学术制图等)帮助作者准备稿件,已助力全球15万+作者顺利发表论文。部分发表范例可查看:服务好评 论文致谢(1篇) 。
提交文稿 | |||||||||||||||||||||
| 是否OA开放访问 | No | |||||||||||||||||||||
| 通讯方式 | AMER ASSOC CANCER RESEARCH, 615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, USA, PA, 19106-4404 | |||||||||||||||||||||
| 出版商 | American Association for Cancer Research Inc. | |||||||||||||||||||||
| 涉及的研究方向 | 医学-肿瘤学 | |||||||||||||||||||||
| 出版国家或地区 | UNITED STATES | |||||||||||||||||||||
| 出版语言 | English | |||||||||||||||||||||
| 出版周期 | Monthly | |||||||||||||||||||||
| 出版年份 | 2001 | |||||||||||||||||||||
| 年文章数 | 154点击查看年文章数趋势图 | |||||||||||||||||||||
| Gold OA文章占比 | 36.23% | |||||||||||||||||||||
| 研究类文章占比: 文章 ÷(文章 + 综述) | 91.56% | |||||||||||||||||||||
| WOS期刊JCR分区 ( 2025-2026年最新版) | 注册或登录后,查看WOS分区等级 | |||||||||||||||||||||
| 期刊分区表预警名单 | 2026年03月发布的新锐学术版:不在预警名单中 2025年03月发布的2025版:不在预警名单中 2024年02月发布的2024版:不在预警名单中 2023年01月发布的2023版:不在预警名单中 2021年12月发布的2021版:不在预警名单中 2020年12月发布的2020版:不在预警名单中 | |||||||||||||||||||||
| 《新锐期刊分区表》 ( 2026年3月发布) | 点击查看期刊分区表趋势图
| |||||||||||||||||||||
| 期刊分区表 ( 2025年3月升级版) |
| |||||||||||||||||||||
| 期刊分区表 ( 2023年12月旧的升级版) |
| |||||||||||||||||||||
| SCI期刊收录coverage | Science Citation Index Expanded (SCIE) (2020年1月,原SCI撤销合并入SCIE,统称SCIE) Scopus (CiteScore) | |||||||||||||||||||||
| PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1535-7163%5BISSN%5D | |||||||||||||||||||||
| 平均审稿速度 | 网友分享经验: 平均3月 | |||||||||||||||||||||
| 平均录用比例 | 网友分享经验: 约50% | |||||||||||||||||||||
| LetPub助力发表 | 经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍,平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务(包括SCI论文英语润色,同行资深专家修改润色,SCI论文专业翻译,SCI论文格式排版,专业学术制图等)后论文在MOLECULAR CANCER THERAPEUTICS顺利发表。
快看看作者怎么说吧:服务好评 论文致谢(1篇) 。 提交文稿 | |||||||||||||||||||||
| 期刊常用信息链接 |
| |||||||||||||||||||||
|
|
| |
| 中国学者近期发表的论文 | |
| 1. | MCT1 Inhibition Remodels the Tumor Immune Microenvironment for Enhanced Cancer Immunotherapy Author: Zhang, Yipeng; Liu, Chun; Han, Fuxin; Tong, Chuan; Guo, Yelei; Lu, Yuting; Han, Weidong; Wang, Yao Journal: MOLECULAR CANCER THERAPEUTICS. 2026; Vol. 25, Issue 8, pp. 1330-1341. DOI: 10.1158/1535-7163.MCT-25-1026 PubMed DOI |
| 2. | TAK-901 Targeted Inhibition of EGFR Activates Transcription Factor FOXO, Causing Cell-cycle Arrest and Apoptosis in Bladder Cancer Author: Lu, Lanpeng; Cheng, Hui; Liu, Shanhui; Tao, Yan; Fu, Shengjun; Lu, Jianzhong; Gong, Yuwen; Ding, Hui; Tian, Junqiang; Li, Lanlan; Wang, Zhiping Journal: MOLECULAR CANCER THERAPEUTICS. 2026; Vol. 25, Issue 8, pp. 1317-1329. DOI: 10.1158/1535-7163.MCT-25-0507 PubMed DOI |
| 3. | VHH-Based CAR-T Cells Targeting DLL3 Show High Efficacy in Small Cell Lung Cancer Models Author: Guo, Han; Yue, Chunjiang; Ma, Di; Zhou, Jingyi; Tang, Min; Sun, Rongze; Tian, Binle; Wang, Zhaoying; Xing, Yishu; Lv, Chenjun; Liu, Chuan; Yuan, Lin; Zhu, Xuekai; Feng, Yunfeng; Li, Qi Journal: MOLECULAR CANCER THERAPEUTICS. 2026; Vol. 25, Issue 8, pp. 1305-1316. DOI: 10.1158/1535-7163.MCT-25-0965 PubMed DOI |
| 4. | A Novel Attenuated CD122-Biased IL15 Mutein Promotes Strong NK and T Cell-Dependent Antitumor Immunity Author: Sun, Mengmeng; Wang, Shuang; Wu, Yue; Xin, Ruipu; Zhang, Shangting; Huang, Bo; Chen, Yan; Liang, Yu; Yu, Tengfei; Xu, Jianqing; Gu, Jijie; Wu, Lei Journal: MOLECULAR CANCER THERAPEUTICS. 2026; Vol. 25, Issue 7, pp. 1049-1063. DOI: 10.1158/1535-7163.MCT-25-0625 PubMed DOI |
| 5. | Identification and Preclinical Evaluation of a Novel GD2 Antibody-Drug Conjugate for Solid Tumors in Children and Adults Author: Song, Deyong; Han, Jing; Dong, Chuangchuang; Wang, Qiaoping; Zhu, Xiaolin; Li, Jing; Rao, Muding; Liu, Hong; Ma, Zhuqing; Teng, Yanni; Dou, Changlin; Xiao, Min Journal: MOLECULAR CANCER THERAPEUTICS. 2026; Vol. 25, Issue 7, pp. 1037-1048. DOI: 10.1158/1535-7163.MCT-25-0728 PubMed DOI |
| 6. | Augmenting Chemokine CCL21 Enhances the Effectiveness of CTLA4 Blockade Immunotherapy for Head and Neck Squamous Carcinoma Author: Liu, Huiyu; Sun, Xiaojiao; Wang, Zhiqi; Liu, Junyan; Feng, Zhien; Dai, Yusong; Yi, Chuxiao; Liu, Zhenming; Li, Tiancheng Journal: MOLECULAR CANCER THERAPEUTICS. 2026; Vol. 25, Issue 7, pp. 1208-1221. DOI: 10.1158/1535-7163.MCT-24-0180 PubMed DOI |
| 7. | Comprehensive Multiplatform Tyrosine Kinase Profiling Reveals Novel Actionable FGFR Aberrations across Sarcomas Affecting the Young Author: Fordham, Ashleigh M.; Brown, Lauren M.; Mayoh, Chelsea; Salib, Alice; Barger, Zara A.; Wong, Marie; Sian, Terry C. C. Lim Kam; Hu, Changyuan; Xie, Jinhan; Gunther, Kate; Trebilcock, Peter; Terry, Rachael L.; Barahona, Paulette; Ajuyah, Pamela; Sherstyuk, Alexandra; Avila, Anica; Cadiz, Roxanne; Perkins, Callum M.; Gifford, Andrew J.; Mao, Jie; Dolman, M. Emmy M.; Zhao, Andrea; O'Regan, Luke P.; Gorgels, Daniel; Lau, Loretta M. S.; Ziegler, David S.; Haber, Michelle; Tyrrell, Vanessa; Lock, Richard B.; Cowley, Mark J.; Nicholls, Wayne; Daly, Roger J.; Ekert, Paul G.; Fleuren, Emmy D. G Journal: MOLECULAR CANCER THERAPEUTICS. 2026; Vol. 25, Issue 7, pp. 1077-1094. DOI: 10.1158/1535-7163.MCT-25-0736 DOI |
| 8. | The Role of Siglec-15 in Tumor Immunity: Mechanisms and Therapy Author: Li, Lin; Wang, Li; Liu, Qin; Ye, Yingchun; Lei, Qian; Li, Chengwen; Guo, Xiyuan; Nian, Siji; Yuan, Qing Journal: MOLECULAR CANCER THERAPEUTICS. 2026; Vol. 25, Issue 5, pp. 717-726. DOI: 10.1158/1535-7163.MCT-25-0323 PubMed DOI |
| 9. | IGFBP3-SphK1/S1P Signaling Axis Drives Enzalutamide Resistance in Advanced Prostate Cancer Author: Leslie, Amy R.; Ning, Shu; Sharifi, Masuda; Schaaf, Zachary A.; Maine, James P.; Lou, Wei; Leslie, Kristina D.; Liu, Chengfei; Xu, Hongyu; Lombard, Alan P.; Chen, Hong-Wu; Parikh, Mamta; Dall'Era, Marc; Gao, Allen C Journal: MOLECULAR CANCER THERAPEUTICS. 2026; Vol. 25, Issue 5, pp. 786-798. DOI: 10.1158/1535-7163.MCT-25-0644 PubMed DOI |
| 10. | Preclinical Development and a Case Report of a Nanobody-Based CLDN18.2 CAR-T IMC002 with Reduced On-Target Off-Tumor Toxicity Author: Du, Sicheng; Zhang, Ying; Hao, Ruidong; Qiu, Lupeng; Li, Chao; Li, Yuting; Liu, Rong-Rui; Zhao, Chuan-Hua; Li, Juan; Ye, Sisi; Zhou, Jun; Li, Yantao; Yi, Qiaoyong; Zhang, Shuangshuang; Sun, Minmin; Luo, Tianhang; Xu, Jianming Journal: MOLECULAR CANCER THERAPEUTICS. 2026; Vol. 25, Issue 5, pp. 701-716. DOI: 10.1158/1535-7163.MCT-25-0171 PubMed DOI |
|
|
|
投稿状态统计: 我要评分: | ||||||||||||||||
| 投稿前担心稿件结构或语言不够规范?试试稿件自查工具,一键检测 >> | ||||||||||||||||
|
||||||||||||||||
同领域作者分享投稿经验:共73条 |
||||||||||||||||
|
|

联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们
© 2010-2026 中国: LetPub上海 网站备案号:沪ICP备10217908号-1
沪公网安备号:31010402006960 (网站)31010405000484 (蝌蝌APP)
增值电信业务经营许可证:沪B2-20211595 网络文化经营许可证:沪网文[2023]2004-152号
礼翰商务信息咨询(上海)有限公司 办公地址:上海市徐汇区漕溪北路88号圣爱大厦1803室